Atosiban Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

What is Atosiban?
Atosiban is a synthetic nonpeptide desamino-oxytocin analog and a competitive vasopressin or oxytocin receptor antagonist. It is used in after assisted reproduction, preterm birth and to halt premature labour due to its ability to decrease contractions and improve uterine receptivity by reducing intracytoplasmic calcium release and downregulate prostaglandin synthesis.

Global Atosiban Market Outlook
Atosiban is a potent stimulator of myometrial contractions and plays an important role in the initiation of both term and preterm labour. Increasing incidence of preterm birth is driving the growth of the atosiban market. An increase in the incidence of multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure among pregnant women is the factor to fuel prevalence. According to the World Health Organization, every year, an estimated 15 million babies are born preterm and this figure is rising year by year. Across 184 countries, the rate of preterm birth ranges from 5% to 18% of babies born. The burden of preventing deaths and complications from preterm birth with a healthy pregnancy is high. These deaths incidence is needed to be prevented with current, cost-effective interventions. However, associated regulatory affairs, lack of hospital facilities and inadequate education about prenatal care in rural areas restrains the growth of the market. Also, atosiban is approved only in 67 countries, excluding the USA and Japan.

Global Atosiban Market Competitive Landscape
The "Global Atosiban Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical and Neore Pharmaceutical. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1. INTRODUCTION OF GLOBAL ATOSIBAN MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL ATOSIBAN MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL ATOSIBAN MARKET, BY TYPE
5.1. Overview
5.2. Injection
5.3. Concentrate

6. GLOBAL ATOSIBAN MARKET, BY APPLICATION
6.1. Overview
6.2. Preterm Birth
6.3. Other

7. GLOBAL ATOSIBAN MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa

8. GLOBAL ATOSIBAN MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Ferring Pharmaceuticals
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Sun Pharma
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Shanghai Soho-Yiming Pharmaceuticals
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. EVER Pharma
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Hangzhou Longshine Bio-Tech
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Cayman Chemical
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Neore Pharmaceutical
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
10. Appendix
10.1. Related Reports
Healthcare and Pharmaceuticals

Global Atosiban Market Analysis 2015-2019 and Forecast 2020-2025

  Price : US$ 2,980   Date : Feb 2020
  Category : Healthcare and Pharmaceuticals   Pages : 86
Healthcare and Pharmaceuticals

Global Atosiban Market Research Report 2020-2024

  Price : US$ 2,850   Date : Dec 2019
  Category : Healthcare and Pharmaceuticals   Pages : 155
Healthcare and Pharmaceuticals

United States Atosiban Acetate Market Report 2019

  Price : US$ 3,800   Date : Jan 2018
  Category : Healthcare and Pharmaceuticals   Pages : 110
Healthcare and Pharmaceuticals

Global Atosiban Acetate Sales Market Report 2019

  Price : US$ 4,000   Date : Dec 2017
  Category : Healthcare and Pharmaceuticals   Pages : 116

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2020 Worldwide Market Reports. All rights reserved